SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of the only commercially available volume‑expanding shape memory polymer for endovascular embolization, announced today that it has completed enrollment in the AAA‑SHAPE Pivotal Trial, a prospective, multicenter, randomized, open‑label controlled study evaluating the safety and effectiveness of the IMPEDE‑FX RapidFill® Device when used alongside endovascular aneurysm repair, or EVAR, to improve abdominal aortic aneurysm (AA
See the full post here as oringinally posted on this site.
